KMT2D c.11593C>T ;(p.Q3865*)

Variant ID: 12-49426895-G-A

NM_003482.3(KMT2D):c.11593C>T;(p.Q3865*)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report.

Drug Design, Development And Therapy
Mao, Shiyu S; Zhang, Junfeng J; Guo, Yadong Y; Zhang, Ziwei Z; Wu, Yuan Y; Zhang, Wentao W; Wang, Longsheng L; Geng, Jiang J; Yan, Yang Y; Yao, Xudong X
Publication Date: 2019

Variant appearance in text: KMT2D: 11593C>T; Gln3865Ter
PubMed Link: 30666091
Variant Present in the following documents:
  • Main text
  • dddt-13-291.pdf
View BVdb publication page